Abbott Laboratories (ABT)
113.38  -0.48 (-0.42%)

Abbott Laboratories is a global healthcare company that specializes in the development of a wide range of medical devices, diagnostics, nutrition products, and pharmaceuticals. The company focuses on innovation to improve patient outcomes and enhance the quality of life for individuals worldwide. Abbott is known for its advancements in areas such as cardiovascular care, diabetes management, and nutrition science, providing essential tools and solutions that support healthcare professionals and patients in managing various health conditions. With a strong commitment to research and development, Abbott continually seeks to address unmet medical needs and contribute to the advancement of healthcare globally.

SummaryNewsPress ReleasesChartHistorical
Previous Close113.86
Open113.85
Bid112.50
Ask113.91
Day's Range112.14 - 114.29
52 Week Range99.71 - 121.64
Volume4,550,901
Market Cap198.52B
PE Ratio (TTM)34.46
EPS (TTM)3.3
Dividend & Yield2.200 (1.94%)
1 Month Average Volume4,725,675

News & Press Releases

Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Thembenzinga.com
Jim Cramer discusses Occidental Petroleum, Cooper Companies, Energy Transfer, Abbott, Kinder Morgan, Advanced Drainage and Archer Aviation.
Via Benzinga · December 11, 2024
“Cardiol Therapeutics (NASDAQ: CRDL) Heart Health Innovation – AVCO, GXAI, UPC, and More Stocks Driving Groundbreaking Advances”
The healthcare and technology sectors are experiencing unprecedented growth as companies push the boundaries of innovation to address critical global challenges. From revolutionary treatments for cardiovascular disease to AI-powered tools and cutting-edge medical devices, these advancements are reshaping industries and creating significant opportunities for investors. Market leaders and emerging innovators alike are driving transformative change, paving the way for a healthier, more connected future.
Via AB Newswire · December 6, 2024
Peering Into Abbott Laboratories's Recent Short Interestbenzinga.com
Via Benzinga · December 6, 2024
ABBOTT LABORATORIES (NYSE:ABT) Technical Analysis observations.chartmill.com
Will ABBOTT LABORATORIES breakout?
Via Chartmill · December 2, 2024
2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Incomefool.com
Via The Motley Fool · November 26, 2024
Analyst Ratings For Abbott Laboratoriesbenzinga.com
Via Benzinga · November 5, 2024
Abbott Surges After Avoiding Another 'Eye-Popping' Verdict In Baby Formula Trialinvestors.com
Lawyers for the plaintiff had been arguing for a $6.2 billion verdict.
Via Investor's Business Daily · November 1, 2024
P/E Ratio Insights for Abbott Laboratoriesbenzinga.com
Via Benzinga · October 22, 2024
ABBOTT LABORATORIES (NYSE:ABT) Reveals Intriguing Technical Aspects. Here's What You Need to Know.chartmill.com
Exploring ABBOTT LABORATORIES's Technical Signals and Breakout Potential.
Via Chartmill · November 25, 2024
2 Dividend Kings to Buy for a Lifetime of Passive Incomefool.com
Via The Motley Fool · November 22, 2024
What To Do After The Worst Week For Healthcare Stocks Since March 2020?talkmarkets.com
The market  was quiet today but we should still expect some gains through year -end albeit a bit choppy.
Via Talk Markets · November 19, 2024
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoidsbenzinga.com
Via Benzinga · November 15, 2024
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Yearsfool.com
These are income stocks you can buy and hold forever.
Via The Motley Fool · November 14, 2024
2 Dividend Kings That Would Have Doubled Your Money in 5 Yearsfool.com
You can be a little greedy sometimes and find great stocks that possess solid growth prospects and also pay dividends.
Via The Motley Fool · November 8, 2024
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Foreverfool.com
You'll also like these stocks for their track record of earnings growth.
Via The Motley Fool · November 8, 2024
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continuesinvestors.com
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.
Via Investor's Business Daily · November 8, 2024
What You Missed On Wall Street This Past Fridaycontent/com
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.
Via Talk Markets · November 3, 2024
AbbVie’s Dividend Isn’t As Scary As It Lookstalkmarkets.com
AbbVie currently pays shareholders a quarterly dividend of $1.55 per share, which gives the stock a 3.3% yield on the current price.
Via Talk Markets · October 30, 2024
These Are The Top Health Stocks to Own for Buy-and-Hold Investing
The stocks on this list are the top three buy-and-hold stocks in healthcare, producing significant value for shareholders while leading their respective fields.
Via MarketBeat · October 30, 2024
3 Dividend Growth Stocks You Can Buy and Hold Foreverfool.com
These healthcare stocks have fantastic dividend track records.
Via The Motley Fool · October 26, 2024
Beat the Nasdaq With This Cash-Gushing Dividend Stockfool.com
The company is performing well despite recently losing its biggest growth driver.
Via The Motley Fool · October 23, 2024
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Foreverfool.com
These companies' longtime shareholders have generally been rewarded.
Via The Motley Fool · October 19, 2024
MarketBeat Week in Review – 10/14 - 10/18
Stocks struggled for direction, but the trend before tech earnings is still bullish. Nevertheless, investors should expect volatility ahead of the election.
Via MarketBeat · October 19, 2024
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Nowfool.com
These stocks could deliver big over the long term.
Via The Motley Fool · October 18, 2024
Stock Market Rally At Highs; Taiwan Semi, ASML, Netflix In Focus: Weekly Reviewinvestors.com
The Dow Jones and S&P 500 hit highs as they extended weekly win streaks.
Via Investor's Business Daily · October 18, 2024